Reduced Nicotine Cigarette Purchasing Decisions
Completed · Early Phase 1
Conditions studied: Tobacco Use Disorder
In brief
The goal of this project is to experimentally evaluate how expectations about reduced-nicotine cigarettes as well as actual nicotine content interact to determine behavioral and subjective response for these novel products.
Key facts
- Study ID
- NCT04999644
- Run by
- Johns Hopkins University
- People needed
- 21
- Starts
- 2022-02-23
- Expected to finish
- 2023-03-29
- Last updated by the study team
- 2024-02-09
Who can join
Age: 21 and older. Sex: any. Healthy volunteers: accepted.
You may qualify if…
- 21 years or older
- Smoke five or more cigarettes per day for the past six months
- Biological confirmation of cigarette use: have an expired carbon monoxide (CO) level of more than 8 ppm and a urinary cotinine level of more than 100 ng per milliliter at screening
You may not qualify if…
- Intention to quit smoking in the next 30 days
- Weekly use of nicotine-containing products other than machine-manufactured combustible cigarettes
- Serious medical or psychiatric disorder precluding participation by study physician guidance
- Positive urine screening for illicit drugs other than cannabis or current substance use disorder
- Women who are pregnant, plan to become pregnant, or are breast-feeding
- Medical contraindications to receiving tobacco products
Where it is running
- Behavioral Pharmacology Research Unit — Baltimore, Maryland, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.